(Reuters) -Pony AI is seeking a valuation of up to $4.48 billion in its U.S. initial public offering, it said on Thursday, as ...

Third Quarter Highlighted by Transformative Agreement and Anticipated Strategic Investment from Infinite Reality including Merger of ...

Conference Call and Webcast Information The Company will host a conference call and webcast today, Thursday, November 14, 2024, at 5:00 p.m. ET. CEO Paul Chang and CFO Bill Williams will lead the call ...

Which stocks are leading the Nasdaq-100 higher in 2024? This diverse bunch of leaders is taking the market by storm.

US stocks slipped on Thursday as the post-election rally paused. Investors assessed the impact of a Republican sweep of political power and awaited a Jerome Powell speech to set the tone on interest ...

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s DiseaseActive ...

The Dow is down 13.88 points or less than a tenth of a percent at 43,944.31, the Nasdaq is down 9.71 points or 0.1 percent ... the French CAC 40 Index is up by 1.2 percent and the U.K.'s FTSE 100 ...

Boston (November 14, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer ...

In the three and nine months ended September 30, 2024, ARK: Survival Evolved and ARK: Survival Ascended combined for an average total of 210,000 and 212,000 daily active users on the Steam and Epic ...

LISBON, Portugal--(BUSINESS WIRE)--Picsart, with over 100 million monthly users, has launched an AI-powered Logo Maker tailored to small businesses, solopreneurs, and side hustlers. Designed for ...

Nov. 13, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (Seres or the Company), a leading ... in each case as compared to placebo, through day 100 post-HSCT. SER-155 was generally ...

Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and EuropeCompleted ZYNQUISTA™ FDA ...